Log in
Enquire now
‌

US Patent 10793535 Heterocyclic glutaminase inhibitors

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Calithera Biosciences
Calithera Biosciences
Date Filed
November 15, 2013
Date of Patent
October 6, 2020
Patent Applicant
Calithera Biosciences
Calithera Biosciences
Patent Application Number
14081175
Patent Citations
‌
US Patent 10316030 Crystal forms of glutaminase inhibitors
‌
US Patent 10258619 Combination therapy with glutaminase inhibitors and immuno-oncology agents
‌
US Patent 10278968 Combination therapy with glutaminase inhibitors
‌
US Patent 10441587 Treatment of lung cancer with inhibitors of glutaminase
Patent Citations Received
‌
US Patent 10940148 Combination therapy with glutaminase inhibitors and immuno-oncology agents
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10793535
Patent Primary Examiner
‌
Po-Chih Chen

Find more entities like US Patent 10793535 Heterocyclic glutaminase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.